Home > Boards > US Listed > Biotechs > MannKind Corp. (MNKD)

News out. Australian Partnership.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
bakersson Member Profile
 
Followed By 10
Posts 655
Boards Moderated 0
Alias Born 08/22/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2019 6:07:20 AM
MannKind to Present at the JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 9:00:00 AM
MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions GlobeNewswire Inc. - 6/9/2019 2:00:00 PM
Afrezza® (insulin human) Inhalation Powder Approved in Brazil GlobeNewswire Inc. - 6/3/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:41:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:31:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:30:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:29:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:28:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:28:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:27:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:27:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:26:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:25:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:25:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:24:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:24:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:24:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:23:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 4:22:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 4:19:33 PM
MannKind Announces Afrezza® Distribution Agreement in Australia GlobeNewswire Inc. - 5/16/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 4:20:38 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/7/2019 8:32:47 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 8:05:02 AM
bakersson   Thursday, 05/16/19 04:54:37 PM
Re: None
Post # of 31586 
News out. Australian Partnership.
On May 16, 2019, MannKind Corporation (“MannKind”) issued a press release announcing MannKind’s entry into an exclusive marketing and
distribution agreement with the AMSL Diabetes division of Australasian Medical & Scientific Ltd. (“AMSL Diabetes”) for the commercialization of
Afrezza® (insulin human) Inhalation Powder in Australia. Under the terms of the agreement, AMSL Diabetes is responsible for obtaining regulatory and
reimbursement approvals to distribute Afrezza in Australia. AMSL Diabetes is also responsible for sales, marketing, and customer support and
distribution activities. MannKind is responsible for the supply and manufacturing of Afrezza.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist